TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name Forskolin
PubChem CID 47936
Molecular Weight 410.5g/mol
Synonyms

Coleonol, colforsin, Forskolin, N,N-dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl ester HCl, NKH 477, NKH-477, NKH477

Formula C₂₂H₃₄O₇
SMILES CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O
InChI 1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1
InChIKey OHCQJHSOBUTRHG-KGGHGJDLSA-N
CAS Number 66575-29-9
ChEMBL ID CHEMBL52606
ChEBI ID CHEBI:42471
Herb ID HBIN026686
Drug Bank ID DB02587
KEGG ID C09076
Toxicity Organism Test Type Route(Dose)
rat LD50 intraperitoneal(165 mg/kg)
mouse LD50 intraperitoneal(254 mg/kg)
rat LD50 oral(322 mg/kg)
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
Plectranthus barbatus Cool
Chineses Pinyin MaoHouQiaoRuiHua
Use Part Whole herb
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Lamiales
    -->Family: Lamiaceae
     -->Genus: Plectranthus
      -->Species: Plectranthus barbatus
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose efficacy can be enhanced by this phytochemical
Hide/Show
Combination Pair ID: 613
Pair Name Forskolin, Paclitaxel
Partner Name Paclitaxel
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Cleavage CASP3 hsa836
Down-regulation Expression CCNA1 hsa8900
Up-regulation Expression CDH1 hsa999
Up-regulation Cleavage PARP1 hsa142
Up-regulation Expression PSMD9 hsa5715
Down-regulation Expression VIM hsa7431
In Vitro Model NCI-H1299 Lung large cell carcinoma Homo sapiens (Human) CVCL_0060
A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
Result Our findings encourage the design of future studies aimed at further exploring the Forskolin employment in NSCLC treatment.
Combination Pair ID: 965
Pair Name Forskolin, Ponatinib
Partner Name Ponatinib
Disease Info [ICD-11: 2A20.1] Chronic myelogenous leukemia Investigative
Gene Regulation Down-regulation Phosphorylation CRKL hsa1399
In Vitro Model KCL-22 Chronic myelogenous leukemia, BCR-ABL1 positive Homo sapiens (Human) CVCL_2091
K-562 Blast phase chronic myelogenous leukemia Homo sapiens (Human) CVCL_0004
HH [Human lymphoma] Primary cutaneous T-cell non-Hodgkin lymphoma Homo sapiens (Human) CVCL_1280
HEK293 Healthy Homo sapiens (Human) CVCL_0045
Hep-G2 Hepatoblastoma Homo sapiens (Human) CVCL_0027
Result This study provides new insight into the biological underpinnings of BCR-ABL-driven CML and potential rationale for investigating novel treatment strategies for patients with T315I CML.
04. Reference
No. Title Href
1 Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axis. Eur J Cell Biol. 2023 Jun;102(2):151292. doi: 10.1016/j.ejcb.2023.151292. Click
2 Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Tumour Biol. 2016 Sep;37(9):12643-12654. doi: 10.1007/s13277-016-5179-7. Click
It has been 26522 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP